{
    "nctId": "NCT00314405",
    "briefTitle": "Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope",
    "officialTitle": "Identification of Sentinel Lymph Node (SLN) in Breast Cancer Care: Clinical and Economical Evaluation of a Double Method Using Isotope and Methylene Blue Dye Injection.",
    "overallStatus": "COMPLETED",
    "conditions": "Infiltrative Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Determination of an optimized protocol for SLN identification, with a double method using isotope and methylene blue dye injection.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patients with infiltrative breast cancer (diagnosed pre-operatively by core biopsy)\n* approval and informed consent\n\nExclusion Criteria:\n\n* chemotherapy\n* locoregional radiotherapy\n* prevalent axillary lymph node",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}